ATXN2 and amyotrophic lateral sclerosis: Further, evaluation of ATXN2 as a disease modifier in patients carrying a C9orf72 expansion mutation suggests that patients with both intermediate ATXN2 repeat lengths and C9orf72 expansions are more susceptible to ALS development (van Blitterswijk et al., 2014).